Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration

Muanpetch Rachayon; Ketsupar Jirakran; Pimpayao Sodsai; Chavit Tunvirachaisakul; Atapol Sughondhabirom; Jie Li; Yingqian Zhang; Michael Maes

doi:10.1016/j.bbih.2025.101066

Back

Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration

Article 2025 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Preprint2024

Immune Cell Exhaustion and Apoptotic Markers in Major Depressive Disorder: Effects of in Vitro Cannabidiol Administration.

Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Chawit Tunvirachaisakul, Atapol Sughondhabirom, Yingqian Zhang, Jie Li

Preprint2022

Effects of cannabidiol on activated immune-inflammatory pathways in major depressive patients and healthy controls

Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Siriwan Klinchanhom, Atapol Sughondhabirom, Kitiporn Plaimas, Apichat Suratanee, Michael Maes

Article2026

Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro

Yingqian Zhang, Qi Lai, Tangcong Chen, Yueyang Luo, M J Li, Mengqi Niu, Jing Li, Michael Maes

Article2022

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response

Adam J. Walker, Mohammadreza Mohebbi, Michael Maes, Michael Berk, Ken Walder, Chiara C. Bortolasci, Zoe Liu, Chee H. Ng, Melanie M. Ashton, Lesley Berk, Ajeet Singh, Gin S. Malhi, Olivia Dean

Book2012

Antidepressants and Major Depressive Disorder

Dan Joseph Stein